Patents by Inventor Zipeng Zhen

Zipeng Zhen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240182592
    Abstract: A multi-specific antibody targeting BCMA. Specifically provided are a multi-specific antibody, a nucleic acid encoding same, a vector including the nucleic acid, a cell including the vector, and a pharmaceutical composition including same. Further provided is the use thereof for treating a subject having a disease related to BCMA expression.
    Type: Application
    Filed: April 14, 2022
    Publication date: June 6, 2024
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Bing ZHANG, Wei ZHAO, Yamin LU, Min DU, Zipeng ZHEN, Meijuan XIE, Xin WANG, Junxiao XI, Xin SONG, Xiuzhen DU
  • Publication number: 20230265181
    Abstract: An immunoglobulin single variable domain and antigen binding molecule binding BCMA, specifically comprising an immunoglobulin single variable domain and antigen binding molecule, a nucleic acid for encoding the binding molecule, a vector containing the nucleic acid, a cell containing the vector, and a pharmaceutical composition containing the above.
    Type: Application
    Filed: August 16, 2021
    Publication date: August 24, 2023
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Zipeng ZHEN, Meijuan XIE, Xiuzhen DU, Yimin MA, Bing ZHANG, Tongjie XU, Xiquan ZHANG
  • Publication number: 20230193292
    Abstract: A BCMA-binding immunoglobulin single variable structural domain and an antigen-binding molecule including an immunoglobulin single variable structural domain and an antigen-binding molecule, a nucleic acid encoding the above, a vector containing the nucleic acid, a cell containing the vector, and a pharmaceutical composition containing the above, as well as a therapeutic use thereof.
    Type: Application
    Filed: August 16, 2021
    Publication date: June 22, 2023
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Zipeng ZHEN, Meijuan XIE, Xiuzhen DU, Yimin MA, Bing ZHANG, Tongjie XU, Xiquan ZHANG
  • Patent number: 10022451
    Abstract: The subject matter disclosed herein relates to compositions that contain a protein cage and a therapeutic agent, such as a photosensitizer. The protein cage is a protein that binds metal ion. The composition can further contain a cell recognition moiety. The methods disclosed are for permeabilizing the endothelial lining of a cancerous tissue or for treating a cancerous tissue to cause therapeutic injury resulting in the reduction of at least one of the surface area, the depth, and the amount of the tissue affected by the cancerous condition, in a subject.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: July 17, 2018
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Jin Xie, Zipeng Zhen, Wei Tang
  • Publication number: 20150320885
    Abstract: The subject matter disclosed herein relates to compositions that contain a protein cage and a therapeutic agent, such as a photosensitizer. The protein cage is a protein that binds metal ion. The composition can further contain a cell recognition moiety. The methods disclosed are for permeabilizing the endothelial lining of a cancerous tissue or for treating a cancerous tissue to cause therapeutic injury resulting in the reduction of at least one of the surface area, the depth, and the amount of the tissue affected by the cancerous condition, in a subject.
    Type: Application
    Filed: May 11, 2015
    Publication date: November 12, 2015
    Inventors: Jin Xie, Zipeng Zhen, Wei Tang